# Enliven Therapeutics funding: rounds and investors

> Enliven Therapeutics has raised $460M across 1 round since 2026. Investors include OrbiMed, Janus Henderson Investors and Cormorant Asset Management.

Source: https://millionrounds.com/company/enliven-therapeutics (Millionrounds; every figure on the page links to its filing or article)

United States · [Funded startup](https://millionrounds.com/companies)

# Who invested in *Enliven Therapeutics*

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 5 months ago

Funding summary Updated 26 Oct 2026

**$460M** raised across 1 round since 2026, from 1 source

- **Latest round:** Round, $460M Jun 2026
- **Investors:** 4

See who backed them

## The rounds

- **Jun 2026** Round **$460M** [OrbiMed](https://millionrounds.com/fund/orbimed) [Janus Henderson Investors](https://millionrounds.com/fund/janus-henderson-investors) [Cormorant Asset Management](https://millionrounds.com/fund/cormorant-asset-management) [5AM Ventures](https://millionrounds.com/fund/5am-ventures) Source recorded

## Founders and team

From Enliven Therapeutics's own website and the SEC filings it signed: 7 on the team.

- **Ben Hohl** Chief Financial Officer and Head of Corporate Development
- **Anish P. Patel** Executive Officer i
- **Benjamin P. Hohl** Executive Officer i
- **Helen P. Collins** Executive Officer i
- **Jake P. Bauer** Board of Directors
- **Joseph P. Lyssikatos** Executive Officer, Director i
- **Samuel Kintz** Executive Officer, Director i

On the board, as filed i *Andrew P. Phillips* *Mika P. Derynck* *Rahul P. Ballal* *Richard P. Heyman* *Rishi P. Gupta*

## Everyone who backed them

[OrbiMed](https://millionrounds.com/fund/orbimed) Private equity **1** round

[Janus Henderson Investors](https://millionrounds.com/fund/janus-henderson-investors) Private equity **1** round

[Cormorant Asset Management](https://millionrounds.com/fund/cormorant-asset-management) Private equity **1** round

[5AM Ventures](https://millionrounds.com/fund/5am-ventures) VC firm **1** round

Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=enliven-therapeutics).

## Quick answers about Enliven Therapeutics

### Who invested in Enliven Therapeutics?

Enliven Therapeutics's investors include OrbiMed, Janus Henderson Investors, Cormorant Asset Management and 5AM Ventures.

### How much has Enliven Therapeutics raised?

Enliven Therapeutics has raised $460M across 1 round since 2026.

### When did Enliven Therapeutics last raise?

Enliven Therapeutics's most recent round was an Undisclosed round of $460M in Jun 2026.

### What was Enliven Therapeutics's biggest round?

Its most recent round, $460M in Jun 2026, is also its largest on record.

### Who backed Enliven Therapeutics first?

Enliven Therapeutics's first round on record, in Jun 2026, was backed by OrbiMed, Janus Henderson Investors and Cormorant Asset Management and 1 others.

### What stage is Enliven Therapeutics at?

Enliven Therapeutics's latest named round is an Undisclosed round, in Jun 2026.

### Where is Enliven Therapeutics based?

Enliven Therapeutics is based in the United States.

## Companies like Enliven Therapeutics

In the same sector, and raised in the last eighteen months.

[**Star Therapeutics** $325M · Oct 2026](https://millionrounds.com/company/star-therapeutics)[**Promaxo** $106M · Oct 2026](https://millionrounds.com/company/promaxo)[**Prolific Machines** $105M · Oct 2026](https://millionrounds.com/company/prolific-machines)[**IMIO** $19M · Oct 2026](https://millionrounds.com/company/imio)[**Clinical Ink** $24M · Oct 2026](https://millionrounds.com/company/clinical-ink)[**Rejuvenate Bio** $13M · Oct 2026](https://millionrounds.com/company/rejuvenate-bio)

## Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app
